Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruifeng Zhou

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Npj Viruses|March 14, 2026
Site-1 protease mediated GPC processing is required for persistence of LCMV Clone 13Ruifeng Zhou, Haydar Witwit, Tingting Ai, et al.
Frontiers in Pharmacology|January 11, 2020
Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, ChinaBin Su, Yin Wang, Ruifeng Zhou, et al.
Epidemiology and Infection|January 28, 2022
Drug resistance characteristics of <i>Mycobacterium tuberculosis</i> isolates obtained between 2018 and 2020 in Sichuan, ChinaRuifeng Zhou, Tianli Zheng, Dongxia Luo, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatmentPatrick Scott Creisher, Jamie L Perry, Weizhei Zhong, et al.
Biorxiv : the Preprint Server for Biology|April 20, 2022
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variantsMengfei Chen, Andrew Pekosz, Jason S Villano, et al.
The Journal of Clinical Investigation|August 15, 2023
Adverse outcomes in SARS-CoV-2-infected pregnant mice are gestational age-dependent and resolve with antiviral treatmentPatrick S Creisher, Jamie L Perry, Weizhi Zhong, et al.
The Journal of Clinical Investigation|March 14, 2024
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variantsMengfei Chen, Andrew Pekosz, Jason S Villano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contactsMatthew L Robinson, Agha Mirza, Nicholas Gallagher, et al.
Journal of Clinical Microbiology|June 22, 2022
Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 ContactsMatthew L Robinson, Agha Mirza, Nicholas Gallagher, et al.
The Journal of Infectious Diseases|December 5, 2022
Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain ReactionHyon S Hwang, Che-Min Lo, Michael Murphy, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Npj Viruses|March 14, 2026
Site-1 protease mediated GPC processing is required for persistence of LCMV Clone 13Ruifeng Zhou, Haydar Witwit, Tingting Ai, et al.
Frontiers in Pharmacology|January 11, 2020
Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, ChinaBin Su, Yin Wang, Ruifeng Zhou, et al.
Epidemiology and Infection|January 28, 2022
Drug resistance characteristics of <i>Mycobacterium tuberculosis</i> isolates obtained between 2018 and 2020 in Sichuan, ChinaRuifeng Zhou, Tianli Zheng, Dongxia Luo, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatmentPatrick Scott Creisher, Jamie L Perry, Weizhei Zhong, et al.
Biorxiv : the Preprint Server for Biology|April 20, 2022
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variantsMengfei Chen, Andrew Pekosz, Jason S Villano, et al.
The Journal of Clinical Investigation|August 15, 2023
Adverse outcomes in SARS-CoV-2-infected pregnant mice are gestational age-dependent and resolve with antiviral treatmentPatrick S Creisher, Jamie L Perry, Weizhi Zhong, et al.
The Journal of Clinical Investigation|March 14, 2024
Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variantsMengfei Chen, Andrew Pekosz, Jason S Villano, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contactsMatthew L Robinson, Agha Mirza, Nicholas Gallagher, et al.
Journal of Clinical Microbiology|June 22, 2022
Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 ContactsMatthew L Robinson, Agha Mirza, Nicholas Gallagher, et al.
The Journal of Infectious Diseases|December 5, 2022
Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain ReactionHyon S Hwang, Che-Min Lo, Michael Murphy, et al.
Pageof 6